Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model.
about
New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.Evaluation by monte carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers.Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasisPharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.Comparative pharmacokinetics of the carbapenems: clinical implications.Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa.The population dynamics of antimicrobial chemotherapy.Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolatesPharmacodynamic profiling of antimicrobials against Gram-negative respiratory isolates from Canadian hospitalsPharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.Retain intermittent dosing of carbapenems.Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.
P2860
Q33622976-C1A34A3E-3479-4D20-BD24-833439138E2DQ33695281-6470FE2D-8FA2-49E5-8663-D4B5B3966395Q33770046-55430C96-89F8-45E1-8826-E6FBAA1C10FAQ33977871-2017EF23-39B7-4D4D-ADFD-F48C1E89219BQ33980421-6A862906-4C8E-4A5F-942D-2AD1048EFEAEQ33981666-46DC1D6E-F79D-45D9-85F9-5126C90C62D0Q34053776-E02F2C69-1E6E-477A-B47D-579C0C0D9B8AQ34228256-E205757A-97A3-4204-8B2F-C0E16431F7FCQ34307105-C2BEA200-3580-490B-BFC3-3A95358DEAF4Q35123667-F5163E6E-F371-4982-96A9-2E1704D1F0F4Q35132378-CE4CC11F-1663-417A-977C-5D20779C5452Q35136449-26B4AFCA-B10F-481F-8458-257A6163D412Q35191501-75E941F5-BA2F-4EC2-A966-9B4491B14E35Q35569189-EF2B65AE-6571-439E-8953-5566C0065CBFQ35819487-F1D55F52-6155-4F3D-BA70-20FEC10ADE9CQ38093135-4C5AD949-A51D-4B39-AD17-6D0029548C6EQ38896040-25026A2D-D70E-490D-A8A7-CC9BE47C55F6Q39781254-4A68145F-EC71-4CE6-BBB6-8BE7AEFCA32FQ40284867-921C77A5-0B8C-4A6C-80C2-B8A6AC5FB11DQ43111815-6D4206AE-DC6D-4A30-874F-4F751433E5B7
P2860
Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Integration of pharmacokinetic ...... n a human-adapted mouse model.
@ast
Integration of pharmacokinetic ...... n a human-adapted mouse model.
@en
type
label
Integration of pharmacokinetic ...... n a human-adapted mouse model.
@ast
Integration of pharmacokinetic ...... n a human-adapted mouse model.
@en
prefLabel
Integration of pharmacokinetic ...... n a human-adapted mouse model.
@ast
Integration of pharmacokinetic ...... n a human-adapted mouse model.
@en
P2093
P2860
P356
P1476
Integration of pharmacokinetic ...... n a human-adapted mouse model.
@en
P2093
Flückiger U
Segessenmann C
P2860
P304
P356
10.1128/AAC.35.9.1905
P407
P577
1991-09-01T00:00:00Z